Impact of Statins in Ischemic Heart Disease (original) (raw)

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease

David Lefer

Cardiovascular Research, 2001

View PDFchevron_right

Basic Science Review Section: Statin Therapy—Part II: Clinical Considerations for Cardiovascular Disease

Benjamin Sadowitz

Vascular and Endovascular Surgery, 2010

View PDFchevron_right

The effects of statins on endothelium, inflammation and cardioprotection

David Lefer

Drug News & Perspectives, 2005

View PDFchevron_right

Statins: targeting cardiovascular disease

Frederick Raal

SA heart, 2017

View PDFchevron_right

Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease

Benjamin Sadowitz

Vascular and endovascular surgery, 2010

View PDFchevron_right

3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes

Neta Blum

Atherosclerosis, 2004

View PDFchevron_right

High-Intensity Statins in Acute Coronary Syndrome Part 1: A look at the pharmacological properties of Statins and clinical trials on Statins in ACS

Utsav Anand Mani

Hypertension journal, 2023

View PDFchevron_right

Statins: 3Hydroxy3-methylglutaryl-CoA (HMG-CoA) Reductase Inhibitors Demonstrate AntiAtherosclerotic Character due to Their Antioxidant Capacity

Mohan Dhale

Applied Biochemistry and Biotechnology, 2011

View PDFchevron_right

Cardiovascular effects of statins, beyond lipid-lowering properties

ANDRES RESTREPO PINEDA

Pharmacological Research, 2014

View PDFchevron_right

Pleiotropic effects of statins: A boulevard to cardioprotection

Aakash Deep

Arabian Journal of Chemistry, 2016

View PDFchevron_right

The evolving role of statins in the management of atherosclerosis

carl vaughan

Journal of the American College of Cardiology, 2000

View PDFchevron_right

Statin therapy--Part II: Clinical considerations for cardiovascular disease

Benjamin Sadowitz

Vascular and endovascular surgery, 2010

View PDFchevron_right

The Rationale for Using HMG-CoA Reductase Inhibitors (‘Statins’) in Peripheral Arterial Disease

Eran Leitersdorf

European Journal of Vascular and Endovascular Surgery, 2007

View PDFchevron_right

The lipid and non-lipid effects of statins

Robin Poston

Pharmacology & Therapeutics, 2003

View PDFchevron_right

Statin mediated protection of the ischemic myocardium

David Lefer

Vascular Pharmacology, 2005

View PDFchevron_right

Cardiac effects of statins—advancements and open questions

M. Bohm

Cardiovascular Research, 2005

View PDFchevron_right

HMG-CoA Reductase Inhibition: Anti-Inflammatory Effects beyond Lipid Lowering?

Heinrich Wieland

European Journal of Cardiovascular Prevention & Rehabilitation, 2003

View PDFchevron_right

Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilities

Robert Rosenson

Atherosclerosis, 2004

View PDFchevron_right

Statins in the prevention of cardiovascular disease

A. Adlouni

2002

View PDFchevron_right

Clinical Significance of Intensive Lipid-Lowering Therapy Using Statins in Patients With Coronary Artery Disease

Hiroyuki Daida

Circulation Journal, 2010

View PDFchevron_right

Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

Raimund Erbel

JAMA, 2006

View PDFchevron_right

The role of statins in heart failure

Erik Øie

Fundamental & Clinical Pharmacology, 2007

View PDFchevron_right

Statins: Can we advocate them for primary prevention of heart disease?

Sougat Ray

Medical Journal Armed Forces India, 2013

View PDFchevron_right

Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins

Germano Sciascio

International Journal of Hypertension, 2011

View PDFchevron_right

Antiatherothrombotic Properties of Statins

Robert Rosenson

JAMA, 1998

View PDFchevron_right

Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms

Yoichi Ogushi

Expert review of clinical pharmacology, 2015

View PDFchevron_right

การประเมินความคุ้มค่าทางการแพทย์ของการใช้ยากลุ่ม HMG-COA reductese inhibitor (Statin) เพื่อป้องกันโรคหัวใจและหลอดเลือดชนิดปฐมภูมิ

STEPHEN LIM

2007

View PDFchevron_right

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

Masami Niwa

2021

View PDFchevron_right

The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient

Hean teik Ong

QJM: An International Journal of Medicine, 2005

View PDFchevron_right

Safety of HMG-CoA Reductase Inhibitors: Focus on Atorvastatin

Andrea Poli

Cardiovascular Drugs and Therapy, 2001

View PDFchevron_right

An overview of statins as hypolipidemic drugs. I

Guru Prasad Mohanta

Int J Pharm Sci Drug Res, 2011

View PDFchevron_right

The Role of Statins in Vascular Disease

Peter Laws, J. Spark

European Journal of Vascular and Endovascular Surgery, 2004

View PDFchevron_right

Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin

Loukianos Rallidis

View PDFchevron_right

Rosuvastatin: A Highly Effective New HMG-CoA Reductase Inhibitor

Ali Raza

Cardiovascular Drug Reviews, 2006

View PDFchevron_right